News
Pushing LDL below 25 mg/dL with alirocumab safe ‘so far’
- Author:
- Bruce Jancin
Key clinical point: LDL cholesterol levels below 25 mg/dL induced by a superpotent investigational lipid-lowering agent appear to be safe through...
News
Adapalene/benzoyl peroxide + doxycycline outscores oral isotretinoin
- Author:
- Bruce Jancin
Key clinical point: The combination of fixed-dose adapalene/benzoyl peroxide plus oral doxycyline is an alternative to oral isotretinoin in...
News
Simple risk score predicts dementia risk in type 2 diabetes
- Author:
- Bruce Jancin
Key clinical point: It’s now readily possible to predict the 10-year dementia risk for individuals with type 2 diabetes.
News
Psoriasis: Brodalumab maintains efficacy through 144 weeks
- Author:
- Bruce Jancin
Key clinical point: The investigational interleukin-17 receptor A inhibitor brodalumab maintained strong clinical efficacy throughout 144 weeks of...
News
Dupilumab advances for severe atopic dermatitis
- Author:
- Bruce Jancin
Key clinical point: A promising new therapy with a novel mechanism of action is progressing through the pipeline for adults with refractory atopic...
News
Dupilumab Advances for Severe Atopic Dermatitis
- Author:
- Bruce Jancin
Key clinical point: A promising new therapy with a novel mechanism of action is progressing through the pipeline for adults with refractory atopic...
News
IMPROVE-IT: Ezetimibe/simvastatin further reduces cardiovascular events
- Author:
- Bruce Jancin
Key clinical point: Combined therapy with ezetimibe and simvastatin reduces cardiovascular events more than simvastatin alone in high-risk...
Video
VIDEO: IMPROVE-IT exonerates ezetimibe, proves LDL hypothesis
- Author:
- Bruce Jancin
News
Increased Alzheimer’s risk with long-term benzodiazepine use
- Author:
- Bruce Jancin
Key clinical point: Chronic use of benzodiazepines by the elderly may boost their risk of Alzheimer’s disease in a dose-dependent fashion.
News
Less daytime sleepiness with lurasidone for schizophrenia
- Author:
- Bruce Jancin
Key clinical point: Patients with an acute exacerbation of schizophrenia treated with lurasidone experience less sleepiness during waking hours,...
News
Certolizumab achieves sustained skin improvement in psoriatic arthritis
- Author:
- Bruce Jancin
Key clinical point: Certolizumab pegol maintains sustained improvement in the dermatologic manifestations of psoriatic arthritis through 96 weeks...
News
Telephone CPR training boosts cardiac arrest survival
- Author:
- Bruce Jancin
Key clinical point: Adoption of the most recent AHA guidelines on telephone CPR by EMS dispatchers will lead to vast improvement in survival for...
News
Switch to long-acting antipsychotics improved treatment attitude
- Author:
- Bruce Jancin
Key clinical point: A switch to a long-acting injectable antipsychotic proved beneficial in multiple ways in patients with schizoaffective...
News
Injectable paliperidone palmitate reduces incarcerations in schizophrenia
- Author:
- Bruce Jancin
Key clinical point: Real world schizophrenia patients with a history of incarceration are less likely to return to jail if they’re on long-acting...
News
Low-risk actinic keratosis? No such thing
- Author:
- Bruce Jancin
Key clinical point: Actinic keratoses traditionally considered low-risk AK 1s with dysplasia confined to the basal one-third of the epidermis can...